Literature DB >> 16864818

The clinical features, MRI findings, and outcome of optic neuritis in children.

M Wilejto1, M Shroff, J R Buncic, J Kennedy, C Goia, B Banwell.   

Abstract

BACKGROUND: Optic neuritis (ON) in childhood is thought to be more likely bilateral and less likely to lead to multiple sclerosis (MS) vs ON in adults.
METHODS: The authors evaluated clinical features, maximal visual deficit and recovery, visual evoked potentials (VEPs), neuroimaging, and outcome in a cohort of children with ON.
RESULTS: Records of 36 children (female/male ratio 1.6), ages 2.2 to 17.8 (mean 12.2) years, were reviewed. ON was unilateral in 58% and bilateral in 42%. Maximal visual deficit was severe in 69%, but full recovery occurred in 39 of 47 affected eyes (83%). VEPs were abnormal in 88%. Neurologic abnormalities in addition to those associated with ON were documented in 13 children. Neuroimaging studies of the optic nerve were abnormal in 55%. Brain MRI in 35 children demonstrated white matter lesions separate from the optic nerves in 54%. Follow-up is 2.4 years (0.3 to 8.3 years). To date, 13 children (36%) have been diagnosed with MS and 1 has Devic disease. Bilateral ON was more likely to be associated with MS outcome (p = 0.03). All 13 children with MS had white matter lesions on brain MRI. None of the children with a normal brain MRI have developed MS to date.
CONCLUSIONS: Contrary to expectations, optic neuritis (ON) in childhood was more likely to be unilateral, multiple sclerosis (MS) risk was high (36% at 2 years), and bilateral rather than unilateral ON was associated with a greater likelihood of MS. Clinical findings extrinsic to the visual system on baseline examination (p < 0.0001) and MRI evidence of white matter lesions outside the optic nerves (p < 0.0001) were strongly correlated with MS outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16864818     DOI: 10.1212/01.wnl.0000224757.69746.fb

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.

Authors:  Grazyna Adamus; Lori Brown; Shayne Andrew; Roberto Meza-Romero; Gregory G Burrows; Arthur A Vandenbark
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

2.  Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists.

Authors:  Amy T Waldman; Mark P Gorman; Mary R Rensel; Tracy E Austin; Deborah P Hertz; Nancy L Kuntz
Journal:  J Child Neurol       Date:  2011-04-25       Impact factor: 1.987

3.  Management of optic neuritis.

Authors:  Vimla Menon; Rohit Saxena; Ruby Misra; Swati Phuljhele
Journal:  Indian J Ophthalmol       Date:  2011 Mar-Apr       Impact factor: 1.848

Review 4.  Acute onset blindness: a case of optic neuritis and review of childhood optic neuritis.

Authors:  Sithara Ramdas; Danny Morrison; Michael Absoud; Ming Lim
Journal:  BMJ Case Rep       Date:  2016-10-04

Review 5.  A Comparison of Optic Neuritis in Asian and in Western Countries.

Authors:  Lin-Chung Woung; Hui-Chuan Chung; Jieh-Ren Jou; Kai-Chen Wang; Pai-Huei Peng
Journal:  Neuroophthalmology       Date:  2011-03-20

6.  Pediatric Optic Neuritis Prospective Outcomes Study.

Authors:  Stacy L Pineles; Grant T Liu; Amy T Waldman; Elizabeth Lazar; Mark J Kupersmith; Michael X Repka
Journal:  J Neuroophthalmol       Date:  2016-06       Impact factor: 3.042

7.  Optic Nerve Measurement on MRI in the Pediatric Population: Normative Values and Correlations.

Authors:  C E Al-Haddad; M G Sebaaly; R N Tutunji; C J Mehanna; S R Saaybi; A M Khamis; R G Hourani
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-07       Impact factor: 3.825

8.  Clinical approach to optic neuropathies.

Authors:  Raed Behbehani
Journal:  Clin Ophthalmol       Date:  2007-09

Review 9.  Visual electrophysiology in the clinical evaluation of optic neuritis, chiasmal tumours, achiasmia, and ocular albinism: an overview.

Authors:  Jelka Brecelj
Journal:  Doc Ophthalmol       Date:  2014-06-25       Impact factor: 2.379

10.  [Acute persistent bilateral loss of vision].

Authors:  C Gaul; K Traufeller; M Krasnianski; J Herde; T Müller
Journal:  Ophthalmologe       Date:  2008-08       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.